Pharma

AstraZeneca ‘mulling split from Chinese business amid rising tensions’

Drugs giant hopes to be better protected against political reprisals from Beijing against foreign companies

  • June 19, 2023
The plan would separate Astra’s Chinese operations into a separate company whose shares would be traded on the Hong Kong or Shanghai stock exchanges. Picture: Getty